Related Experiment Videos
OMERACT 7 psoriatic arthritis workshop: synopsis
D D Gladman1, V Strand, P J Mease
1University of Toronto, Western Research Institute, Psoriatic Arthritis Program, Toronto Western Hospital, Ontario M5T 2S8, Canada. dafna.gladman@utoronto.ca
Annals of the Rheumatic Diseases
|February 15, 2005
Summary
The Outcome Measures in Rheumatology (OMERACT) conference established consensus on key outcome measures for psoriatic arthritis clinical trials. This work proposes a research agenda for psoriatic arthritis studies.
Area of Science:
- Rheumatology
- Clinical Trial Methodology
Background:
- The Outcome Measures in Rheumatology (OMERACT) conference employs a consensus-driven process for identifying clinical trial outcome measures.
- A dedicated workshop at OMERACT 7 focused on psoriatic arthritis outcome measures.
Framework:
- Previous Delphi exercises and nominal group processes informed the workshop discussions.
- Results from clinical trials using biological therapies in psoriatic arthritis were presented.
Implementation:
- Participants engaged in breakout group discussions.
- Evidence presented and group discussions guided the consensus process.
Implications:
- A set of essential domains for psoriatic arthritis clinical trials was defined.
- A forward-looking research agenda for psoriatic arthritis was proposed.